Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

66.06
-0.1000-0.15%
Volume:179.93K
Turnover:11.90M
Market Cap:3.37B
PE:22.24
High:67.55
Open:66.18
Low:65.63
Close:66.16
52wk High:88.77
52wk Low:58.39
Shares:51.01M
Float Shares:27.58M
Volume Ratio:0.47
T/O Rate:0.65%
Dividend:2.48
Dividend Rate:3.75%
EPS(TTM):2.97
EPS(LYR):2.97
ROE:27.27%
ROA:15.26%
PB:6.12
PE(LYR):22.24

Loading ...

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Dow Jones
·
23 mins ago

Cybin (Helus Pharma) Names Veteran Pharma Executive Michael Cola as CEO to Drive CNS Growth

TIPRANKS
·
17 hours ago

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

GlobeNewswire
·
Yesterday

CNS Pharmaceuticals Restructures Finance Leadership, Appoints New CFO

TIPRANKS
·
Feb 17

Cellectar Biosciences Expands Global Intellectual Property Estate

GlobeNewswire
·
Feb 17

Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis

GlobeNewswire
·
Feb 17

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.

GlobeNewswire
·
Feb 17

Francis C. Poli, GC, Secretary, and EVP, Reports Disposal of Cohen & Steers Inc. Common Shares

Reuters
·
Feb 13

Press Release: ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS

Dow Jones
·
Feb 12

LG CNS Secures KRW240.9 Billion Data Center Construction Project

MT Newswires Live
·
Feb 12

A Look At Cohen & Steers (CNS) Valuation After AUM Growth And Resilient Earnings

Simply Wall St.
·
Feb 10

Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences

GlobeNewswire
·
Feb 10

PreveCeutical Files Patent for Direct Brain Delivery of Dopamine and CNS Drugs

TIPRANKS
·
Feb 10

Cohen & Steers Posts Higher Assets Under Management in January

MT Newswires Live
·
Feb 09

Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

GlobeNewswire
·
Feb 09

BRIEF-Cohen & Steers Announces Preliminary Assets Under Management And Net Flows For January 2026

Reuters
·
Feb 09

Cohen & Steers Inc - Reports Aum of $93.1 Bln as of Jan 31, 2026

THOMSON REUTERS
·
Feb 09

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for January 2026

THOMSON REUTERS
·
Feb 09

Gilead Sciences Says Yescarta Won FDA Label Update, Removing Use Limits for Relapsed CNS Lymphoma Patients

MT Newswires Live
·
Feb 06

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 06